The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Various cyclin-dependent kinase (Cdk) complexes have been implicated in the regulation of transcription. In this study, we identified a 70-kDa Cyclin K (CycK) that binds Cdk12 and Cdk13 to form two different complexes (CycK/Cdk12 or CycK/Cdk13) in human cells. The CycK/Cdk12 complex regulates phosphorylation of Ser2 in the C-terminal domain of RNA polymerase II and expression of a small subset of human genes, as revealed in expression microarrays. Depletion of CycK/Cdk12 results in decreased expression of predominantly long genes with high numbers of exons. The most prominent group of down-regulated genes are the DNA damage response genes, including the critical regulators of genomic stability: BRCA1 (breast and ovarian cancer type 1 susceptibility protein 1), ATR (ataxia telangiectasia and Rad3-related), FANCI, and FANCD2. We show that CycK/Cdk12, rather than CycK/Cdk13, is necessary for their expression. Nuclear run-on assays and chromatin immunoprecipitations with RNA polymerase II on the BRCA1 and FANCI genes suggest a transcriptional defect in the absence of CycK/Cdk12. Consistent with these findings, cells without CycK/Cdk12 induce spontaneous DNA damage and are sensitive to a variety of DNA damage agents. We conclude that through regulation of expression of DNA damage response genes, CycK/Cdk12 protects cells from genomic instability. The essential role of CycK for organisms in vivo is further supported by the result that genetic inactivation of CycK in mice causes early embryonic lethality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Micro3 showed similarities to HM_3, HM_4 phenotype but also expressed APOE, apoptosis associated genes XAF1, YWHAB, YWHAG, YWHAE encoding 14–3-3 protein subunits, cell-cycle and cell division control genes CDK12, MIS18BP1, TAF1D, BOD1L1 and CCAR1 [6, 30, 67].”
From Characterisation of premature cell senescence in Alzheimer's disease using single nuclear transcriptomics (2024) · cites this paper as [6]
In the citing paper
“To execute their functions, CDK12 and CDK13 form two separate complexes with CCNK (Blazek et al., 2011; Cheng et al., 2012).”
From Discovery of a molecular glue promoting CDK12-DDB1 interaction to trigger cyclin K degradation (2020) · cites this paper as Blazek et al., 2011
In the citing paper
“CDK12 inactivation is known to cause reduced POLII elongation and premature polyadenylation of select genes enriched in the DNA damage response pathway, resulting in a BRCAness phenotype (Blazek et al., 2011; Dubbury et al., 2018; Johnson et al., 2016).”
From Discovery of a molecular glue promoting CDK12-DDB1 interaction to trigger cyclin K degradation (2020) · cites this paper as Blazek et al., 2011
In the citing paper
“CDK12 forms a complex with CCNK to act as a transcriptional regulator of genes critically involved in DDR pathways (Blazek et al., 2011;Krajewska et al., 2019).”
From Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer (2021) · cites this paper as Blazek et al., 2011
Citations
Cites
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,925
The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092 · cited 4×
“DDR operates through a large network of proteins; however, some proteins lie at the core of DDR mechanisms and regulate responses to several types of lesions (Matsuoka et al. 2007; Jackson and Bartek 2009; Ciccia and Elledge 2010).”
BackgroundInfluentialThe DNA Damage Response: Making It Safe to Play with Knives
Ciccia, A., & Elledge, S. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.019 · Cited by 4,368
ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075 · cited 2×
“DDR operates through a large network of proteins; however, some proteins lie at the core of DDR mechanisms and regulate responses to several types of lesions (Matsuoka et al. 2007; Jackson and Bartek 2009; Ciccia and Elledge 2010).”
BackgroundThe DNA Damage Response: Ten Years After
Harper, J. W., & Elledge, S. J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.11.015 · Cited by 1,705
Bonner, W. M., Redon, C. E., Dickey, J. S., Nakamura, A. J., Sedelnikova, O. A., Solier, S., & Pommier, Y. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2523 · Cited by 1,623 · cited 2×
“DNA double-stranded breaks (DSBs) and DNA interstrand cross-links (ICLs) are among the most severe DNA lesions (Harper and Elledge 2007; Bonner et al. 2008; Jackson and Bartek 2009; Moldovan and D’Andrea 2009).”
Backgroundc-Myc Regulates Transcriptional Pause Release
Rahl, P. B., Lin, C. Y., Seila, A. C., Flynn, R. A., McCuine, S., Burge, C. B., Sharp, P. A., & Young, R. A. (2010) · Cell · doi:10.1016/j.cell.2010.03.030 · Cited by 1,279 · cited 1×
“P-TEFb is considered to be the major Ser2 kinase and was implicated in the regulation of transcriptional elongation of most, if not all, protein-coding genes (Chao et al. 2000; Nechaev and Adelman 2008; Rahl et al. 2010).”
BackgroundControlling the elongation phase of transcription with P-TEFb
Peterlin, B. M., & Price, D. H. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.014 · Cited by 1,144 · cited 3×
“Phosphorylation of serine at position 2 (Ser2) is thought to be responsible for productive transcriptional elongation and synthesis of full-length mature mRNA (Peterlin and Price 2006; Bres et al. 2008).”
BackgroundSelf-citationRecruitment of P-TEFb for Stimulation of Transcriptional Elongation by the Bromodomain Protein Brd4
Yang, Z., Yik, J. H. N., Chen, R., He, N., Jang, M. K., Ozato, K., & Zhou, Q. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.029 · Cited by 1,138 · cited 13×
“To determine how depletion of P-TEFb and the CycK/Cdk12 complex affects BRCA1 protein levels and global phosphorylation of Ser2, we knocked down both cyclin subunits of P-TEFb and the CycK/Cdk12 complex (Fig.”
BackgroundInfluentialiCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution
König, J., Zarnack, K., Rot, G., Curk, T., Kayikci, M., Zupan, B., Turner, D. J., Luscombe, N. M., & Ule, J. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1838 · Cited by 1,126 · cited 1×
“CEL files were first analyzed with version 3 of ASPIRE software (Konig et al. 2010).”
MethodSelf-citation
Research works printed but not linked: 1
- 10.1038/nature10166 · DOI · Paper page
Cited by
Items 401–500 of 542
Pandurangan, T., Zeleke, S. T., Iermolaieva, A., Ghosh, P., Mosior, J., Sun, L., Grassie, D., Schmitz, M., Kalaga, M. N., Albritton, W., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02086 · Cited by 4
Thomas, J., Lubaba, F., Subair, S., Mahin, A., Gopalakrishnan, A. P., Shivamurthy, P. B., Rajeev, A. C., & Raju, R. (2026) · OMICS A Journal of Integrative Biology · doi:10.1177/15578100251414655 · Cited by 2
“On the other hand, the negative association with CDK12, a kinase involved in transcription and RNA processing (Blazek et al., 2011), may re fl ect a compensatory or transcriptionally coupled mechanism in response to SLC6A15 activity changes.”
Roles of CDK12/CDK13 and development of inhibitors and degraders
Li, Z. F., Ke, Y., Zhang, R., Zhang, R., & Zhang, L. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119077 · Cited by 4
RNA-binding proteins TDP-43 and FUS promote R-loop resolution and regulate transcription termination
Zhao, D. Y., Nabeel‐Shah, S., Ni, Z., Pu, S., Zhong, G., Schmitges, F. W., Braunschweig, U., Blencowe, B. J., & Greenblatt, J. F. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111348 · Cited by 4
Kawahara, S., Taki, M., Hamanishi, J., Ebara, S., Murakami, R., Hamada, K., Watanabe, K., Hosoe, Y., Mise, Y., Takamatsu, S., et al. (2026) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-25-0954 · Cited by 3
Ye, D., Zhao, Y., Yang, L., Sun, X., Cao, T., Yuan, M., Qiao, T., Xing, L., & Sun, X. (2026) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2026.102545 · Cited by 2
Santos, E. S. D., Cicilini, A. L., Simões, M. F. E., Baz, M., Caputo, S. M., & Rouleau, É. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156754 · Cited by 5
“It regulates gene transcription, RNA splicing, translation, cell cycle, cell proliferation, DDR and maintenance of genomic stability [92,93].”
Regulation of RNA transcript elongation in metazoans and its relevance to disease
Mimoso, C. A., Fianu, I., & Adelman, K. (2026) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-026-01003-w · Cited by 2
CRISPR/Cas9 Technology Providing the Therapeutic Landscape of Metastatic Prostate Cancer
Park, J., & Kim, J. (2024) · Pharmaceuticals · doi:10.3390/ph17121589 · Cited by 4
Lost in Transcription: Molecular Mechanisms that Control
Taube, R., Peterlin, B. M., Segal, S., & Russell, R. L. (2013) · Cited by 2
Self-citationLack of evidence for CDK12 as an ovarian cancer predisposing gene
Eeckhoutte, A., Saint‐Ghislain, M., Reverdy, M., Raynal, V., Baulande, S., Bataillon, G., Golmard, L., Stoppa‐Lyonnet, D., Popova, T. G., Houdayer, C., et al. (2020) · Familial Cancer · doi:10.1007/s10689-020-00169-2 · Cited by 2
Défauts de la recombinaison homologue et inhibiteurs de PARP en thérapeutique
Salaün, H., Saint‐Ghislain, M., Bellesœur, A., Beuzeboc, P., Neuzillet, C., Dieras, V. C., Stern, M., & Rodrigues, M. J. (2021) · Bulletin du Cancer · doi:10.1016/j.bulcan.2021.09.015 · Cited by 2
Relay of cyclin-dependent kinases in the regulation of axonal growth.
Chang, T.-Y., & Cheng, P.-L. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.06.019 · Cited by 2
“alternative splicing and genomic stability (Blazek et al., 2011; Chen et al., 2006), indirectly maintained Cdk5 levels and regulated axon ex-”
BackgroundRiedlinger, G., Jalloul, N., Poplin, E. A., Mehnert, J. M., Groisberg, R., Khiabanian, H., & Ganesan, S. (2019) · JCO Precision Oncology · doi:10.1200/po.19.00193 · Cited by 2
Sanchez, G., Barbier, J., Elie, C., Kiernan, R. E., & Rouquier, S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.17.297960 · Cited by 2
Ang, H. X., Sutiman, N., Deng, X. L., Bartelt, L. C., Chen, Q., Barrera, A., Lin, J., Sheng, J., McDowell, I. C., Reddy, T. E., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.03.433762 · Cited by 2
CDK12/13 inhibitor, CTX-439, suppresses tumor growth and potentiates BCL-2 family blockadePreprint
Yamakawa, H., Khatab, R., Mizutani, A., Ebara, S., Hirayama, T., Tanaka, S., Tarumoto, Y., Sugiyama, M., Sugino, S., Takano, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.20.706902 · Cited by 4
Targeting CDKs with Other Chemotherapeutic Drugs: A Combinatorial Approach
Mir, M. A., & Mir, U. Y. (2023) · Springer eBooks · doi:10.1007/978-981-19-8911-7_13 · Cited by 1
Li, Y., Gong, J., Sun, Q., Vong, E. G., Cheng, X., Wang, B., Yuan, Y., Li, J., Gamazon, E. R., Zhou, D., et al. (2024) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2024.01.010 · Cited by 2
Pilania, P., Nandi, S., Meena, D. K., & Sharma, B. K. (2024) · Current Signal Transduction Therapy · doi:10.2174/0115743624279638240211170045 · Cited by 1
CDK12 inhibition reveals melanoma dependence on the RUNX1/CBFβ complex for genomic stability
Boucher, J. G., Houlès, T., Berliocchi, E., Lavoie, G., MacLeod, G. D. A. H., Saba-El-Leil, M. K., Angers, S., Meloche, S., & Roux, P. P. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116495 · Cited by 3
Li, H., Luo, J., Liang, H., Yanfeng, B., Liu, J., Wei, T., Wang, L., Guo, H., Xia, D., Huang, H., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-25-1761 · Cited by 2
Lee, H., Ho, J.-N., Song, S. H., Oh, J. J., Huh, J. S., Kim, H.-M., Kim, K. H., Kim, S., & Byun, S.-S. (2025) · The World Journal of Men s Health · doi:10.5534/wjmh.250093 · Cited by 1
“CDK12 is known to plays several crucial roles in cellular processes, primarily revolving around genome stability and gene expression regulation [27].”
Therapeutic targeting of CDK12: a medicinal chemistry perspective
Wang, F., Dai, H., Wan, K., & Wang, M. (2026) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2026.118552 · Cited by 1
Hu, L., Zhong, W., Wang, L., Liang, S., 贾云献, Wu, Z., Shen, J., Sun, J., & Qian, A. (2026) · Bone and Joint Research · doi:10.1302/2046-3758.157.bjr-2025-0343.r1 · Cited by 1
“As CDK12 phosphorylates Serine 2 (Ser2) of RNAPII to regulate downstream target gene expression, 11,15,32 we then detected the expression and phosphorylation of RNAPII ([P-Ser2] RNAPII) in osteoblasts treated by mechanical unloading.”
The Less Known Cyclins—Uncovered
Żuryń, A., Opacka, A., Krajewski, A., Zielińska, W., & Grzanka, A. (2021) · Applied Sciences · doi:10.3390/app11052320 · Cited by 1
“Cells depleted of cycK-Cdk12 were sensitive to various DNA damaging factors, including camptothecin, mitomycin C and etoposide [72].”
BackgroundOvarian cancer treatment strategies: focus on PARP inhibitors
Li, Z., & Li, H. (2023) · International Conference on Modern Medicine and Global Health (ICMMGH) · doi:10.1117/12.2692606 · Cited by 1
Xing, H., & Yau, C. (2024) · BMC Bioinformatics · doi:10.1186/s12859-024-05682-0 · Cited by 2
“On the other hand, CCNK is complexed with kinase CDK12 and CDK13 [5, 9], which are strongly associated with BRCA [13], AML [21] and diffuse large B-cell lymphoma (DLBCL) [8].”
BackgroundStructure-independent machine-learning predictions of the CDK12 interactome
Karolak, A. M., Urbaniak, K., Monastyrskyi, A., Duckett, D. R., Branciamore, S., & Stewart, P. A. (2024) · Biophysical Journal · doi:10.1016/j.bpj.2024.05.017 · Cited by 1
Liang, L., Zhu, K., Tao, J., & Lu, S. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008792 · Cited by 1
“Its upstream module includes CDK13 [37], H3F3A [38], IDH1 [39], PTEN [40], SNRPE [41] that are closely related to DNA repair or DNA replication.”
BackgroundShah, S. P. (2016) · San José State University ScholarWorks (San Jose State University) · doi:10.31979/etd.32pr-8xtr · Cited by 2
“The cyclin K/cdk12 complex regulates the phosphorylation of ser2 on the CTD domain of RNA Pol II, and is involved in the expression of long genes that have many exons (Blazek et al., 2011).”
BackgroundIdentification of Potential Genes in Her2+ Breast Cancer by Co-expression Network AnalysisPreprint
Li, X., Wang, Y., Wang, Z., Yao, G., Fan, J., Liang, G., & Wang, X. (2020) · doi:10.21203/rs.3.rs-26134/v1 · Cited by 1
Frank, S. B., Persse, T. W., Coleman, I., Bankhead, A., Li, D., Sarkar, N. D., Wilson, D., Rudoy, D., Vashisth, M., Galipeau, P., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.16.603734 · Cited by 5
Frank, S. B., Persse, T. W., Coleman, I., Bankhead, A., Li, D., Sarkar, N. D., Wilson, D., Rudoy, D., Vashisth, M., Galipeau, P., et al. (2025) · eLife · doi:10.7554/elife.100081.2 · Cited by 3
Andrade, F. D. O. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2014.tde-27052015-121330 · Cited by 1
Disruption of DNA Repair by Cell Cycle and Transcriptional CDK Inhibition
Cornell, L., Johnson, N., & Shapiro, G. I. (2015) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-14151-0_17 · Cited by 1
Procesos que regulan la transcripción en eucariotas
Martínez, A. G. (2012) · Gredos (University of Salamanca) · doi:10.14201/gredos.121359
Insights into the RNA Polymerase CTD code
Schüller, R. (2013) · doi:10.5282/edoc.16565
Targeting the Cell Cycle for Cancer Treatment and Neuroprotection
Dai, Y., Chen, S., Liang, Y., & Xu, M. (2013) · Springer eBooks · doi:10.1007/978-94-007-6211-4_23
The effects of biotic and abiotic stressors on gene expression in chickens
Coble, D. (2013) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-180810-3243
The Role of CDK2 and CDK9 in the Radiation Response of human HNSCC Cancer Cells
Soffar, A. A. (2013) · Qucosa (Saxon State and University Library Dresden)
Almada, A. E. (2013) · DSpace@MIT (Massachusetts Institute of Technology)
CDK12 IS A NOVEL ONCOGENE WITH CLINICAL AND PATHOGENETIC RELEVANCE IN BREAST CANCER
Taglialatela, A. (2013) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/taglialatela-angelo_phd2013-03-04
MicroRNAs and epigenetics in chemical carcinogenesis : an integrative toxicogenomics-based approach
Rieswijk, L. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20160120lr
The Role of RNF40 mediated H2B monoubiquitination in transcription
Xie, W. (2017) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6125
Carneiro, T. N. R. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.41.2017.tde-28032017-153312
Insights Into Chromatin Modification and FANCD2 Phosphorylation in DNA Damage Repair
Vierra, D. A. (2017) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-vierra-david-2017
Tam, A., Mathew, V., Sihota, T. S., Zhang, A., & Stirling, P. C. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/272807
“Still other groups have suggested that splicing factor disruption, such as loss of CDK12, causes changes in gene expression, which reduce the activity of canonical genome maintenance factors leading to defects in DNA repair (Blazek et al., 2011).”
BackgroundClinical Utility of Poly (ADP-Ribose) Polymerase Inhibitors in Ovarian Cancer
Bhatia, D. R., & Gupta, S. (2018) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000551
“Key HRR genes that are regulated through CDK12 include BRCA1, ATR, FANCI and FANCD2 [74].”
BackgroundMolecular cloning and homology modelling of human Cyclin Dependent Kinase 3 (CDK3)
Shawish, A. N. M. S. (2017)
Magen, A., Das, A., Lee, J. S., Sharmin, M., Lugo, A., Gutkind, J. S., Schäffer, A. A., Ruppin, E., & Hannenhalli, S. S. (2018) · SSRN Electronic Journal · doi:10.1101/253120
Positive transcription elongation factor b and its regulators in development
Wang, Y., & Qiu, T. (2019) · All Life · doi:10.1080/21553769.2019.1663277
Regulation of alternative polyadenylation in Drosophila melanogaster
Oliveira, M. (2019) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/zrjc-r941
Novel Drug Treatments for Ewing Sarcoma
Hayden, R., & Leggas, M. L. (2019) · Current Molecular Biology Reports · doi:10.1007/s40610-019-00125-9
ORN: Extracting Latent Pathway Activities in Cancer with OR-gate NetworkPreprint
Liang, L., Zhu, K., & Lu, S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.07.137992
“Its upstream module includes CDK13 (22), H3F3A (23), IDH1 (24), PTEN (25), SNRPE (26) that are closely related to DNA repair or DNA replication.”
BackgroundDevelopment of molecular inhibitor nanoformulations for cancer therapy
Baldwin, P. (2019) · Digital Repository Service (Northeastern University) · doi:10.17760/d20317945
Cyclin-Dependent Kinase as a Novel Therapeutic Target: An Endless Story
Etman, A. M., Mageed, S. S. A., Ali, M. A., & Hassab, M. A. E. (2020) · Current Chemical Biology · doi:10.2174/2212796814999201123194016
Identification of New Key Genes in Breast Cancer by Co-expression Network AnalysisPreprint
Li, X., Wang, Y., Wang, Z., Yao, G., Fan, J., Liang, G., & Wang, X. (2020) · doi:10.21203/rs.3.rs-23381/v1
New treatment strategy for ovarian cancer with a BRCA gene mutation
(2021) · European Journal of Gynaecological Oncology · doi:10.31083/j.ejgo.2021.01.2251
“Knockdown of cyclin-dependent kinase 12 (CDK12) results in concomitant downregulation of DNA repair proteins, thereby leading to the development of a “BRCAness” phenotype [46].”
BackgroundInvestigating the Role of CDK11 in Animal Cytokinesis
Panagiotou, T. C. (2020) · TSpace (University of Toronto)
Sarkar, G. C., Rautela, U., Goyala, A., Datta, S., Anand, N., Singh, A., Singh, P., Chamoli, M., & Mukhopadhyay, A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.03.482777
Matsumoto, A. M. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735700601.793561158
Mohammad, E. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9383
Cyclin‐dependent kinase 12‐mediated super‐enhancers as promising targets in cancer therapy
Xie, F., Chen, B., Liu, X., Yu, J. Q., To, K. F., & Kang, W. (2022) · Clinical and Translational Discovery · doi:10.1002/ctd2.146
Tumor suppression by RNA surveillance
Fisher, R. P. (2023) · Science · doi:10.1126/science.adh4051
Hampl, M., Jandová, N., Lusková, D., Novakova, M., Procházka, J., Kohoutek, J., & Buchtová, M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.23.537955
“CDK13 is one of the transcriptional kinases, which regulates transcription via phosphorylation of the RNA Polymerase II and control alternative splicing (Bartkowiak et al., 2010, Blazek et al., 2011).”
BackgroundSelf-citationResearch progress in small-molecule modulators of protein-protein interactions
Yang, B., & Qi, X. (2023) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2023-0034
Coelho, K. B. C. A. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2023.tde-05062023-114237
Rautela, U., Sarkar, G. C., Chaudhary, A., Chatterjee, D., Rosh, M., Arimbasseri, G. A., & Mukhopadhyay, A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.09.570929
Tracking down metabolic vulnerabilities in CDK12‐mutant prostate cancer
Tu, W., Wang, M., & Chen, M. (2024) · Clinical and Translational Discovery · doi:10.1002/ctd2.345
PROTACs of cyclin-dependent kinases
Veselá, D., Řezníčková, E., Mik, V., & Jorda, R. (2024) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2024.10.003
Frank, S. B., Persse, T. W., Coleman, I., Bankhead, A., Li, D., Sarkar, N. D., Wilson, D., Rudoy, D., Vashisth, M., Galipeau, P., et al. (2024) · eLife · doi:10.7554/elife.100081.1 · Cited by 2
la Mora, J. D.-D., Assaad, M. A., Quitian, S., Levine, M. F., Deshpande, A. S., Sigouros, M., Manohar, J., Medina-Martinez, J. S., Sboner, A., Elemento, O., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155782
Genes as Genome Stabilizers in Pluripotent Stem Cells
Karmakar, A., Augustine, A. B. H. R., & Thummer, R. P. (2025) · Advances in experimental medicine and biology · doi:10.1007/5584_2025_853
Wang, Y., Yu, A., Gao, Z., Yuan, X., Du, X., Shi, P., Guan, H., Wen, S., Wang, H., Wang, L., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1568665
“Current diagnostic protocols employ multiparametric magnetic resonance imaging (mpMRI) as the primary imaging modality for patients presenting with elevated prostate-speci fi c antigen (PSA) levels, followed by histological con fi rmation via biopsy or postprostatectomy analysis (5).”
InfluentialKang, S. W., Tran, H. T., Lee, G., Ng, J., Lim, S. B., & Kim, E. Y. (2025) · iScience · doi:10.1016/j.isci.2025.112457
“73 Collectively, these results suggest that the effect of RNAPII CTD Ser5 phosphorylation might vary in a gene-specific manner, with per being particularly sensitive to such regulation.”
Research Progress of PROTAC-Degraded CDKs in the Treatment of Breast Cancer
Zhao, K., Zhang, J., Yang, Z., Wang, R., Shi, Y., Ji, Y., Zhang, S., & Liu, M. (2025) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s527906 · Cited by 4
Kosibaty, Z., Luck, C., & Okimoto, R. A. (2025) · Oncogene · doi:10.1038/s41388-025-03507-9 · Cited by 1
“In particular, fusion-positive Ewing sarcoma cells (A673 and TC32) exhibit exquisite sensitivity to THZ531, a CDK12/13 inhibitor, resulting in the downregulation of the homologous recombination (HR) and DNA damage check-point genes, including BRCA1, ATR, FANCl, and FANCD2 [34, 35].”
Overexpression of CCNK Leads to Early Resumption of Meiosis in Mouse Oocytes
Xu, Y., Sun, S., Zhao, B., Guo, J., Yang, X., Lu, Y., Zhang, Y., Ji, D., & Wang, Z. (2025) · Molecular Reproduction and Development · doi:10.1002/mrd.70075
“…elongation by phosphorylating the left open reading frame 1 (Leo1) subunit of the RNA polymerase II ‐ associated factor 1 complex (PAF1C), thereby facilitating the phosphorylation of serine (Ser2) on the C ‐ terminal domain (CTD) of RNA polymerase II (Blazek et al. 2011; Fan et al. 2020).”
UNCOVERING THE MECHANISM OF CHROMATIN ASSOCIATION OF THE PAF1 TRANSCRIPTION ELONGATION COMPLEX
Mayekar, M. K. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
Lautert-Dutra, W., M. Melo, C., Chaves, L. P., Crozier, C., P. Saggioro, F., B. dos Reis, R., Bayani, J., Bonatto, S. L., & Squire, J. A. (2024) · Figshare · doi:10.6084/m9.figshare.26716228
Lautert-Dutra, W., M. Melo, C., Chaves, L. P., Crozier, C., P. Saggioro, F., B. dos Reis, R., Bayani, J., Bonatto, S. L., & Squire, J. A. (2024) · Figshare · doi:10.6084/m9.figshare.26716240
Cesari, E., Ciucci, A., Pieraccioli, M., Caggiano, C., Nero, C., Bonvissuto, D., Sillano, F., Buttarelli, M., Piermattei, A., Loverro, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26590215
Lautert-Dutra, W., M. Melo, C., Chaves, L. P., Crozier, C., P. Saggioro, F., B. dos Reis, R., Bayani, J., Bonatto, S. L., & Squire, J. A. (2024) · Figshare · doi:10.6084/m9.figshare.26716234
Lautert-Dutra, W., M. Melo, C., Chaves, L. P., Crozier, C., P. Saggioro, F., B. dos Reis, R., Bayani, J., Bonatto, S. L., & Squire, J. A. (2024) · Figshare · doi:10.6084/m9.figshare.26716231
Cesari, E., Ciucci, A., Pieraccioli, M., Caggiano, C., Nero, C., Bonvissuto, D., Sillano, F., Buttarelli, M., Piermattei, A., Loverro, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26590212
Cesari, E., Ciucci, A., Pieraccioli, M., Caggiano, C., Nero, C., Bonvissuto, D., Sillano, F., Buttarelli, M., Piermattei, A., Loverro, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26590209
Lautert-Dutra, W., M. Melo, C., Chaves, L. P., Crozier, C., P. Saggioro, F., B. dos Reis, R., Bayani, J., Bonatto, S. L., & Squire, J. A. (2024) · Figshare · doi:10.6084/m9.figshare.26716225
Cesari, E., Ciucci, A., Pieraccioli, M., Caggiano, C., Nero, C., Bonvissuto, D., Sillano, F., Buttarelli, M., Piermattei, A., Loverro, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26590218
Lautert-Dutra, W., M. Melo, C., Chaves, L. P., Crozier, C., P. Saggioro, F., B. dos Reis, R., Bayani, J., Bonatto, S. L., & Squire, J. A. (2024) · Figshare · doi:10.6084/m9.figshare.26716219
Lautert-Dutra, W., M. Melo, C., Chaves, L. P., Crozier, C., P. Saggioro, F., B. dos Reis, R., Bayani, J., Bonatto, S. L., & Squire, J. A. (2024) · Figshare · doi:10.6084/m9.figshare.26716243
Lautert-Dutra, W., M. Melo, C., Chaves, L. P., Crozier, C., P. Saggioro, F., B. dos Reis, R., Bayani, J., Bonatto, S. L., & Squire, J. A. (2024) · Figshare · doi:10.6084/m9.figshare.26716237
Du, X., Qin, W., Yang, C., Dai, L., San, M., Xia, Y., Zhou, S., Wang, M., Wu, S., Zhang, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26708906
Du, X., Qin, W., Yang, C., Dai, L., San, M., Xia, Y., Zhou, S., Wang, M., Wu, S., Zhang, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26708903
Du, X., Qin, W., Yang, C., Dai, L., San, M., Xia, Y., Zhou, S., Wang, M., Wu, S., Zhang, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26708900
Lautert-Dutra, W., M. Melo, C., Chaves, L. P., Crozier, C., P. Saggioro, F., B. dos Reis, R., Bayani, J., Bonatto, S. L., & Squire, J. A. (2024) · Figshare · doi:10.6084/m9.figshare.26716222
Zeng, L., Li, Y., Liu, J., Liu, C., Gao, N., He, J., & Zhang, Y. (2026) · Molecular Genetics and Genomics · doi:10.1007/s00438-025-02341-8 · Cited by 1
“Notably, RORA and KPNA1 are involved in immune regulation and antiviral responses, while CDK13 and PABPC1 regulate transcription and mRNA metabolism (Blazek et al. 2011).”
Metadata
- Authors
- Blazek, D., Kohoutek, J., Bartholomeeusen, K., Johansen, E., Hulinkova, P., Luo, Z., Cimermancic, P., Ule, J., & Peterlin, B. M.
- Affiliations
- University of California, San Francisco (US)
- MRC Laboratory of Molecular Biology (GB)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2011-10-15
- Volume
- 25
- Issue
- 20
- Pages
- 2158-2172
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC3205586
- OpenAlex
- W2123814549
- Cited by
- 522
- References
- 57
- Citations by year
- 2026: 40 · 2025: 36 · 2024: 52 · 2023: 40 · 2022: 35 · 2021: 40 · 2020: 52 · 2019: 45 · 2018: 33 · 2017: 24 · 2016: 29 · 2015: 25 · 2014: 23 · 2013: 24 · 2012: 24
- Type
- posted content
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Genes & Development (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Wellcome Trust (089701)
- Grantová Agentura České Republiky
- National Institutes of Health (GM082250)
- National Institute of General Medical Sciences (P50GM082250, IP50 GM082250)
- National Institute of Allergy and Infectious Diseases (R01AI49104, R01AI049104)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- cyclin K, CDK12, CDK13, RNA polymerase II Ser2 phosphorylation, transcriptional regulation, DNA damage response genes, genome stability, BRCA1, ATR, FANCI, FANCD2, spontaneous DNA damage, embryonic lethality
- MeSH terms
- Animals, DNA Damage, HeLa Cells, Humans, Phosphorylation, CDC2 Protein Kinase, Cyclins, Mice, Knockout, Gene Expression Regulation, Developmental, Cyclin-Dependent Kinases, Genomic Instability, Cyclin-Dependent Kinase 9, Mice, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.